I think they are the company to watch, but I guess I mean this from a scientific point of view. I am not planning on loading up as soon as they go public.
Still, it was my impression that they raised millions (or hunderds of millions) as a private company, and money talks...
Still, I will be waiting on the sidelines mainly because I want to see how well RNAi can be delivered as a drug. As a research tool, it is great, but that's not enough to make a profitable public company.